Register Organization
Username:
Password:
Forgot Password?

Skip Navigation Links
******* Meaningful Use Public Health Measure *******
Facilities which have completed Stage 2 attestments and are sending ongoing production data submissions will have their 2015 attestment period automatically updated to calendar year 2016 on Jan. 4, 2016. Additional registration for 2016 is not needed.
*** New ***
ISDH Registries can accept attestments for Stage 3 MU beginning January 1st 2017. Providers wishing to attest for Stage 3, should be meeting the existing Stage 2 ongoing submission of messages. Providers previously enrolled for Stage 2 will need to register their intent for each facility that is attesting for Stage 3. No changes in terms of process for reporting - ELR, Syndromic Surveillance and Cancer registries. Immunization Registry, CHIRP can accept Stage 3 type messages (QBP,RSP) and a range of vaccine codes include the NDC, CVX and CPT codes. Stage 3 attestments may begin with the CVX type code and migrate at a later point to NDC. At this time CVX is still the preferred code.
Stage 1 Requirements Resources
Cancer is not participating in Stage 1 Meaningful Use ISDH Meaningful Use Self Service Registry Guide



Stage 2 Requirements Resources
Cancer Reporting applies only to Eligible Providers.
Message format must be in HL7 CDA format.
Messages must pass NIST Context-free Validation tests using NIST online tools for cancer reporting. NIST Meaningful Use Cancer Registry Report Validation
Messages must be successfully received ongoing for 90 day period. NIST-Cancer Tools Portal
Transport Method is Web Plus or PHINMS.